Dr. Margaret Callahan, chief of UConn Health's Division of Hematology and Oncology, joins Dr. Anthony Alessi's podcast
Dr. Margaret Callahan (left), chief of UConn Health's Division of Hematology and Oncology, joins Dr. Anthony Alessi on his "Healthy Rounds" podcast at UConn Health. (File photos)
The idea of using cells from your own tumor to develop a personalized vaccine that guides your immune system to fight your cancer goes back several decades. Today, we are on the verge of using messenger RNA to bring this concept to a new level, one that could change how we treat melanoma and other cancers. Dr. Margaret Callahan(opens in new tab), chief of UConn Health's Division of Hematology and Oncology and medical director of the clinical trials office, joins Dr. Anthony Alessi(opens in new tab) to explain how immunotherapy works and why it holds so much promise.
T
hese therapies, they don't work directly on the cancers. They work on your immune system, and let your immune system do the job. — Dr. Margaret Callahan
Listen now:
